Ensocell is a Life Science company utilising cutting-edge single cell genomics technologies, AI-based computational tools, and advanced cell models to identify novel disease intervention points and to discover novel therapeutics for autoimmune, inflammatory, and fibrotic diseases. Founded by leading scientists at Sanger Institute, the company is located at the Babraham Research Campus, Cambridge.
| Website | http://www.ensocell.com/ |
| Employees | 20 (14 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Cell Engineering, Single Cell Genomics, Regenerative Medicine, Ai Driven Drug Discovery, Cell Therapy, Biotechnology, Therapeutics, Autoimmune Diseases, Precision Medicine, Drug Development, Computational Biology, Genomics, Immunology, Inflammation, Biomarker Discovery, Molecular Biology, Data Science |
| Competitors | GE HealthCare, Roche, Thermo Fisher Scientific, Merck Group, FUJIFILM Business Innovation Asia Pacific, Lonza, Illumina, Bio-Rad Laboratories, Miltenyi Biotec, Greiner Bio One International GmbH +47 more (view full list) |
Looking for a particular Ensocell employee's phone or email?
Qianxin Wu is the Co-Founder, Head of Target Biology of Ensocell.
14 people are employed at Ensocell.